SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-23-069070
Filing Date
2023-03-13
Accepted
2023-03-13 16:15:59
Documents
4
Group Members
AVENTIS INC.ZEST ACQUISITION SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-C d479675dsctoc.htm SC TO-C 13912
2 EX-99.1 d479675dex991.htm EX-99.1 33317
3 GRAPHIC g479675dsp4.jpg GRAPHIC 2827
4 GRAPHIC g479675dsp5.jpg GRAPHIC 1356
  Complete submission text file 0001193125-23-069070.txt   55094
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Subject) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-90545 | Film No.: 23727506
SIC: 2834 Pharmaceutical Preparations